MeiraGTx Holdings (MGTX) Other Operating Expenses (2024 - 2025)
MeiraGTx Holdings (MGTX) reported Other Operating Expenses of $476000.0 for Q4 2025, down 95.97% on a YoY basis from $11.8 million in Q4 2024, and up 52.08% quarter-over-quarter from $313000.0 in Q3 2025.
MeiraGTx Holdings (MGTX) Other Operating Expenses (2024 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Other Operating Expenses for 2 years, with the latest figure at $476000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Operating Expenses fell 95.97% year-over-year to $476000.0; the trailing twelve-month figure through Dec 2025 stood at $4.8 million (down 79.64% YoY), and the FY2025 full-year result was $4.8 million, down 79.64% from the prior year.
- Other Operating Expenses for Q4 2025 stood at $476000.0, up from $313000.0 in the prior quarter.
- The five-year high for Other Operating Expenses was $12.0 million in Q3 2024, with the low at $313000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 476,000.00 |
| Sep 30, 2025 | 313,000.00 |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 11.81 Mn |
| Sep 30, 2024 | 11.99 Mn |